US FDA approves second over-the-counter opioid overdose reversal drug

(Reuters) – The U.S. Food and Drug Administration has approved the prescription-free sale of the second opioid overdose reversal drug, its manufacturer Harm Reduction Therapeutics said on Friday. The approval of the drug, called RiVive, will provide patients with another over-the-counter option in the United States, where drug-related overdose deaths surpassed 100,000 in 2021. Harm…

Read More

Apple Soars Toward a Blue-Sky Run: iStock Exhibits Bullish Patterns After Fed’s Rate Call

Apple, Inc (NASDAQ:AAPL) exhibited a 1.6% increase on Friday, following a predominantly upward trajectory within a rising channel pattern. The Cupertino, California-based company’s current pattern indicates a bullish outlook, at least for the short-term. Additionally, Apple is currently trading within an inside bar pattern, signaling a period of consolidation that typically precedes a continuation of…

Read More

Unraveling Microsoft Stock’s Friday Surge: Latest Updates and Developments

Microsoft Corp (NASDAQ: MSFT) stock is experiencing gains on Friday as it highlights the significant role of graphics processing units (GPUs) as a critical raw material for its expanding cloud business, specifically in enabling AI capabilities. The company’s annual report addressed GPUs as a risk factor, citing potential outages if the necessary infrastructure is not…

Read More

Factbox-The legal troubles of former U.S. President Donald Trump

(Reuters) – Here is a list of legal troubles facing former U.S. President Donald Trump, the front-runner for the 2024 Republican presidential nomination. Trump, 77, denies any wrongdoing. JAN. 6 AND THE U.S. CAPITOL ATTACK U.S. Attorney General Merrick Garland is investigating Trump’s role in actions surrounding his loss in the 2020 presidential election that…

Read More